ArticleFrontiers in oncology2022

Prognostic efficacy and prognostic factors of TACE plus TKI with ICIs for the treatment of unresectable hepatocellular carcinoma: A retrospective study.

Ziqiang Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.